These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 8746621)
1. An open study of mupirocin in Libyan patients with skin infections. El Ferghani N J Int Med Res; 1995; 23(6):508-17. PubMed ID: 8746621 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Gisby J; Bryant J Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346 [TBL] [Abstract][Full Text] [Related]
3. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice. Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167 [TBL] [Abstract][Full Text] [Related]
4. Hydrocortisone acetate alone or combined with mupirocin for atopic dermatitis in infants under two years of age - a randomized double blind pilot trial. Canpolat F; Erkoçoğlu M; Tezer H; Kocabaş CN; Kandi B Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1989-93. PubMed ID: 23242727 [TBL] [Abstract][Full Text] [Related]
6. [A trial of the use of mupirocin in the nasal carriage of Staphylococcus aureus in medical personnel]. Dmitrieva NV; Solodovnik FI; Petukhova IN Antibiot Khimioter; 2000; 45(3):35-8. PubMed ID: 10768065 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial. Bork K; Brauers J; Kresken M Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463 [TBL] [Abstract][Full Text] [Related]
8. [Mupirocin: prophylaxis of hospital-acquired infections due to Staphylococcus aureus and sanitation of hospital environment]. Mitrokhin SD Antibiot Khimioter; 2003; 48(9):13-9. PubMed ID: 15002175 [TBL] [Abstract][Full Text] [Related]
9. Anti-biofilm properties of a mupirocin spray formulation against Escherichia coli wound infections. Bakkiyaraj D; Sritharadol R; Padmavathi AR; Nakpheng T; Srichana T Biofouling; 2017 Aug; 33(7):591-600. PubMed ID: 28686044 [TBL] [Abstract][Full Text] [Related]
10. Susceptibility of skin and soft-tissue isolates of Staphylococcus aureus and Streptococcus pyogenes to topical antibiotics: indications of clonal spread of fusidic acid-resistant Staphylococcus aureus. Afset JE; Maeland JA Scand J Infect Dis; 2003; 35(2):84-9. PubMed ID: 12693555 [TBL] [Abstract][Full Text] [Related]
11. Microbiological profile of a new topical antibacterial: retapamulin ointment 1%. Scangarella-Oman NE; Shawar RM; Bouchillon S; Hoban D Expert Rev Anti Infect Ther; 2009 Apr; 7(3):269-79. PubMed ID: 19344241 [TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. Sesso R; Barbosa D; Leme IL; Sader H; Canziani ME; Manfredi S; Draibe S; Pignatari AC J Am Soc Nephrol; 1998 Jun; 9(6):1085-92. PubMed ID: 9621293 [TBL] [Abstract][Full Text] [Related]
14. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Semret M; Miller MA Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789 [TBL] [Abstract][Full Text] [Related]
15. A comparison of the efficacy and safety of mupirocin cream and cephalexin in the treatment of secondarily infected eczema. Rist T; Parish LC; Capin LR; Sulica V; Bushnell WD; Cupo MA Clin Exp Dermatol; 2002 Jan; 27(1):14-20. PubMed ID: 11952661 [TBL] [Abstract][Full Text] [Related]
16. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults. Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of mupirocin calcium ointment in the treatment of experimental wound infections caused by methicillin-resistant strains of Staphylococcus aureus. Beale AS; Gisby J; Sutherland R J Chemother; 1989 Jul; 1(4 Suppl):397-8. PubMed ID: 16312457 [No Abstract] [Full Text] [Related]
18. Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic. Rittenhouse S; Singley C; Hoover J; Page R; Payne D Antimicrob Agents Chemother; 2006 Nov; 50(11):3886-8. PubMed ID: 17065626 [TBL] [Abstract][Full Text] [Related]
19. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial. Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105 [TBL] [Abstract][Full Text] [Related]
20. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections. Odom RB Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]